Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2007 1
2008 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Postmenopausal hormone therapy: cardiovascular risks.
[No authors listed] [No authors listed] Prescrire Int. 2003 Apr;12(64):65-9. Prescrire Int. 2003. PMID: 12674130
On the contrary, both risks increased. (7) The increased incidence of deep venous thrombosis and/or pulmonary embolism associated with estrogen-progestin replacement therapy was confirmed in these trials, even among women with no relevant history. (8) The WHI …
On the contrary, both risks increased. (7) The increased incidence of deep venous thrombosis and/or pulmonary embolism associated with es …
Where are we with postmenopausal hormone therapy in 2005?
Lam PM, Chung TK, Haines C. Lam PM, et al. Gynecol Endocrinol. 2005 Nov;21(5):248-56. doi: 10.1080/09513590500279733. Gynecol Endocrinol. 2005. PMID: 16373243 Review.
Recently, two large randomized placebo-controlled studies on long-term postmenopausal hormone replacement therapy, the Heart and Estrogen/progestin Replacement Study (HERS) and the Women's Health Initiative (WHI), have raise a lot of controversies, especially …
Recently, two large randomized placebo-controlled studies on long-term postmenopausal hormone replacement therapy, the Heart and Estrogen …
Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey.
Sawka AM, Huh A, Dolovich L, Papaioannou A, Eva K, Thabane L, Gafni A, Cullimore A, Macdougall M, Steiner M, Adachi JD. Sawka AM, et al. J Obstet Gynaecol Can. 2004 Nov;26(11):967-73. doi: 10.1016/s1701-2163(16)30418-2. J Obstet Gynaecol Can. 2004. PMID: 15560859
Knowledge of the findings of the estrogen/progestin arm of the WHI study did not significantly differ among users of different types of hormone preparations. Of the women who indicated that they did not know if HT affected the risk of WHI-studied medic …
Knowledge of the findings of the estrogen/progestin arm of the WHI study did not significantly differ among users of di …
NIH and WHI: time for a mea culpa and steps beyond.
Utian WH. Utian WH. Menopause. 2007 Nov-Dec;14(6):1056-9. doi: 10.1097/gme.0b013e3181589bfe. Menopause. 2007. PMID: 17975521
The termination of the estrogen-progestin arm of the Women's Health Initiative (WHI) 5 years ago was abrupt and poorly planned. ...Another factor was the utilization of a nonvalidated index termed the "global health index" that inexplicably assumed for compar …
The termination of the estrogen-progestin arm of the Women's Health Initiative (WHI) 5 years ago was abrupt and poorly …
Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C. Sammartino A, et al. J Endocrinol Invest. 2005;28(10 Suppl):80-4. J Endocrinol Invest. 2005. PMID: 16550729 Review.
However, recent studies such as the Women's Health Initiative (WHI) trial and the Heart and Estrogen/Progestin Replacement Study (HERS) I and II has forced practitioners to reconsider their options for prevention of CVD in post-menopausal women. The increased …
However, recent studies such as the Women's Health Initiative (WHI) trial and the Heart and Estrogen/Progestin Replacem …
Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.
Barrett-Connor E, Cauley JA, Kulkarni PM, Sashegyi A, Cox DA, Geiger MJ. Barrett-Connor E, et al. J Bone Miner Res. 2004 Aug;19(8):1270-5. doi: 10.1359/JBMR.040406. Epub 2004 Apr 12. J Bone Miner Res. 2004. PMID: 15231013 Free article. Clinical Trial.
INTRODUCTION: The Women's Health Initiative (WHI) trial reported overall risks that exceeded benefits from use of estrogen-progestin in healthy postmenopausal women. ...A global index of clinical outcomes, defined as described for the WHI trial (the ea …
INTRODUCTION: The Women's Health Initiative (WHI) trial reported overall risks that exceeded benefits from use of estrogen- …
Experiences of a long-term randomized controlled prevention trial in a maiden environment: Estonian Postmenopausal Hormone Therapy trial.
Hovi SL, Veerus P, Rahu M, Hemminki E. Hovi SL, et al. BMC Med Res Methodol. 2008 Aug 1;8:51. doi: 10.1186/1471-2288-8-51. BMC Med Res Methodol. 2008. PMID: 18673555 Free PMC article.
RESULTS: After EPHT recruited in 1999-2001 the Women's Health Initiative (WHI) in the USA decided to stop the estrogen-progestin trial after a mean of 5.2 years in July 2002 because of increased risk of breast cancer and later in 2004 the estrogen-only trial …
RESULTS: After EPHT recruited in 1999-2001 the Women's Health Initiative (WHI) in the USA decided to stop the estrogen-prog …
Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma?
Machens K, Schmidt-Gollwitzer K. Machens K, et al. Hum Reprod. 2003 Oct;18(10):1992-9. doi: 10.1093/humrep/deg406. Hum Reprod. 2003. PMID: 14507812 Review.
In July 2002 the data of the prematurely stopped Estrogen plus Progestin study of the Women's Health Initiative (WHI) were presented in the Journal of the American Medical Association. The results of the Heart and Estrogen/Progestin Replacement Study (HERS/HE …
In July 2002 the data of the prematurely stopped Estrogen plus Progestin study of the Women's Health Initiative (WHI) were presented …